The therapeutic efficacy of guided therapy for PCI after acute myocardial infarction: A meta-analysis

Author:

Sun Meixia1ORCID,Ding Yi2,Chen Kang1,He Yanwen1,Zhang Yukun1,Zhuo Yue1,Zhuang He1ORCID

Affiliation:

1. School of Rehabilitation Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China

2. The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.

Abstract

Objective: To systematically evaluate the effects of lead therapies on percutaneous coronary intervention (PCI) after acute myocardial infarction (AMI). Methods: A randomized controlled trial (RCT) in the CNKI, Wanfang, VIP, ProQuest, PubMed, Cochrane Library, Scopus, and Web of Science databases was searched until January 2023. Two researchers strictly screened and checked the included literature, extracted relevant data, and used the Cochrane Manual to assess the risk quality of the literature. Using RevMan 5.3 software, Meta-analysis of 4 main outcome measures [cardiac function-related indicators, 6-minute walking distance (6 MWT), quality of life (SF-36), Seattle angina pectoris scale (SAQ)], and 3 secondary outcome measures [adverse event incidence, death incidence, and readmission rate]. Results: 22 studies were finally included with 1754 subjects, but the overall quality of the included studies was not high. The results of the meta-analysis showed that, in the cardiac function-related indicators compared to controls, improved left ventricular ejection fraction (LVEF) index (MD = 1.42, 95%CI [−0.94, 3.79], P < .00001); however, compared with the Baduanjin group, Tai Chi ball + Baduanjin group and control group, there was no significant difference (P > .05); compared with the control group, the guidance therapy group improved the left ventricular end-diastolic volume (LVEDV) index (MD = −4.67, 95%CI [−6.8, −2.71], P < .00001). In comparison, the lead group improved the 6 MWT (MD = 69.44, 95%CI [30.12, 108.76], P < .00001); the SF-36 score (MD = 10.05, 95%CI [8.68, 11.42], P < .00001])and the SAQ score (MD = 6.2, 95%CI [3.97, 8.44], P < .00001). Among the secondary outcome measures, the incidence of adverse events was statistically significant (RR = 0.17, 95%CI [0.1, 0.32], P < .00001); statistically significant (RR = 0.29, 95%CI (0.1, 0.87), P < .00001); readmission (RR = 0.39, 95%CI [0.17, 0.87, 0.89], P < .00001). Conclusion: Based on the current study, combining conventional therapy/ exercise or using simple lead therapy after PCI can improve the treatment effect and improve the quality of life.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference36 articles.

1. Development of MACE and their risk factors after PCI treatment in elderly patients with multimorbidity complicated by acute myocardial infarction.;Li;Chinese J Gerontol,2022

2. Progress in TCM treatment and research of acute myocardial infarction Chinese Journal of Evidence-based Cardiovascular Medicine, 2022,14 (04): 504-506 Wei Na, Zhu Meng Effect of stage I cardiac rehabilitation combined with PCI in patients with acute myocardial infarction.;Li;Mod Med Health,2023

3. Effect of amiodarone combined with metoprolol in patients with acute myocardial infarction complicated with arrhythmia and its effect on patient cardiac function Chinese.;Lian;J Chinese folk therapy,2019

4. Efficacy of emergency PCI combined with intracoronary thrombus aspiration in acute myocardial infarction.;Xu;J Hunan Normal Univ (Medical edition),2021

5. Clinical effect of postthrombolysis in transit PCI and direct PCI for acute ST-segment elevation myocardial infarction.;Feng;J Integr TCM Western Med Cardiovasc Cerebrovasc Dis,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3